<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Skin manifestations associated with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) may reveal bone marrow transformation into <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: The objective of this study was to assess the prevalence of skin manifestations associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, we evaluated the risk of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> transformation associated with skin manifestations </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We studied a cohort of 157 patients with primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> followed up prospectively for a median of 44 months </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001212'>Skin lesions</z:mp> were prospectively assessed as part of medical examination every 6 months by a board certified dermatologist </plain></SENT>
<SENT sid="5" pm="."><plain>Survival analyses were performed to assess the association between the presence of <z:mp ids='MP_0001212'>skin lesions</z:mp> and the risk of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Fifteen patients (9.55%) experienced <z:mp ids='MP_0001212'>skin lesions</z:mp> previously reported as associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These were <z:e sem="disease" ids="C1142272" disease_type="Disease or Syndrome" abbrv="">neutrophilic dermatosis</z:e> (7, 4.46%), specific lesions (5, 3.18%), cutaneous <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (2, 1.27%) and <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et disease (1, 0.63%) </plain></SENT>
<SENT sid="8" pm="."><plain>Survival analysis showed that the risk of transformation into <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> was slightly but not significantly increased in patients with <z:mp ids='MP_0001212'>skin lesions</z:mp> as compared with patients without <z:mp ids='MP_0001212'>skin lesions</z:mp> with a relative risk of 2.08 (95% CI 0.92-4.67) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: The prevalence of <z:mp ids='MP_0001212'>skin lesions</z:mp>, mostly <z:e sem="disease" ids="C1142272" disease_type="Disease or Syndrome" abbrv="">neutrophilic dermatosis</z:e> and specific lesions, is relatively high in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>There is a trend for a higher risk of transformation into <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> in patients with <z:mp ids='MP_0001212'>skin lesions</z:mp> </plain></SENT>
</text></document>